BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 15996031)

  • 1. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.
    Blandizzi C; Fornai M; Colucci R; Natale G; Lubrano V; Vassalle C; Antonioli L; Lazzeri G; Del Tacca M
    World J Gastroenterol; 2005 Jul; 11(26):4052-60. PubMed ID: 15996031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
    Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
    Natale G; Lazzeri G; Lubrano V; Colucci R; Vassalle C; Fornai M; Blandizzi C; Del Tacca M
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):62-72. PubMed ID: 14962506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
    Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C
    Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
    Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
    Dig Dis Sci; 1999 Oct; 44(10):2039-50. PubMed ID: 10548356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats.
    Tsuji S; Sun WH; Tsujii M; Kawai N; Kimura A; Kakiuchi Y; Yasumaru S; Komori M; Murata H; Sasaki Y; Kawano S; Hori M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1301-8. PubMed ID: 12438555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.
    Pozzoli C; Menozzi A; Grandi D; Solenghi E; Ossiprandi MC; Zullian C; Bertini S; Cavestro GM; Coruzzi G
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):283-91. PubMed ID: 17151854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
    Kuroda M; Yoshida N; Ichikawa H; Takagi T; Okuda T; Naito Y; Okanoue T; Yoshikawa T
    Int J Mol Med; 2006 Jan; 17(1):89-93. PubMed ID: 16328016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
    Fukuda T; Arakawa T; Shimizu Y; Ohtani K; Higuchi K; Kobayashi K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S5-7. PubMed ID: 7594340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin-induced morphological changes in the rat gastric mucosa, with or without prior treatment with two proton pump inhibitors.
    Morini G; Grandi D; Arcari ML; Bertaccini G
    Aliment Pharmacol Ther; 1995 Dec; 9(6):615-23. PubMed ID: 8824648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat.
    Chandranath SI; Bastaki SM; Singh J
    Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):173-80. PubMed ID: 11906479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA.
    Batista LM; de Almeida AB; de Pietro Magri L; Toma W; Calvo TR; Vilegas W; Souza Brito AR
    Biol Pharm Bull; 2004 Mar; 27(3):328-32. PubMed ID: 14993797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroprotective effects of pantoprazole against experimental mucosal damage.
    Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
    Fundam Clin Pharmacol; 2000; 14(2):89-99. PubMed ID: 10796055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
    Murakami I; Asano S; Yukishige K; Nagaya H; Satoh H; Inatomi N
    Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):323-32. PubMed ID: 9017686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
    Morini G; Grandi D; Arcari ML; Bertaccini G
    Gen Pharmacol; 1995 Sep; 26(5):1021-5. PubMed ID: 7557244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal.
    Maity P; Bindu S; Choubey V; Alam A; Mitra K; Goyal M; Dey S; Guha M; Pal C; Bandyopadhyay U
    J Biol Chem; 2008 May; 283(21):14391-401. PubMed ID: 18375387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of capsaicin-sensitive sensory neurons and nitric oxide in the protective effect of lansoprazole, a proton pump inhibitor, on the gastric mucosa in rats.
    Murakami I; Satoh H; Asano S; Maeda R
    Jpn J Pharmacol; 1996 Oct; 72(2):137-47. PubMed ID: 8912915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats.
    Zinkievich JM; George S; Jha S; Nandi J; Levine RA
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):654-61. PubMed ID: 20082628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine.
    Slomiany BL; Piotrowski J; Slomiany A
    Scand J Gastroenterol; 1997 Jul; 32(7):638-42. PubMed ID: 9246701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.